UnicoCell Biomed Co., Ltd. (6794.TW)

TWD 70.8

(0.28%)

Net Debt Summary of UnicoCell Biomed Co., Ltd.

  • UnicoCell Biomed Co., Ltd.'s latest annual net debt in 2023 was 54.43 Million TWD , up 320.31% from previous year.
  • UnicoCell Biomed Co., Ltd.'s latest quarterly net debt in 2024 Q2 was 38.18 Million TWD , down -33.07% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported annual net debt of 12.95 Million TWD in 2022, up 111.85% from previous year.
  • UnicoCell Biomed Co., Ltd. reported annual net debt of -109.27 Million TWD in 2021, up 41.87% from previous year.
  • UnicoCell Biomed Co., Ltd. reported quarterly net debt of 57.05 Million TWD for 2024 Q1, up 4.82% from previous quarter.
  • UnicoCell Biomed Co., Ltd. reported quarterly net debt of 19.73 Million TWD for 2023 Q2, down 0.0% from previous quarter.

Annual Net Debt Chart of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Historical Annual Net Debt of UnicoCell Biomed Co., Ltd. (2023 - 2019)

Year Net Debt Net Debt Growth
2023 54.43 Million TWD 320.31%
2022 12.95 Million TWD 111.85%
2021 -109.27 Million TWD 41.87%
2020 -187.98 Million TWD 0.0%
2019 - TWD 0.0%

Peer Net Debt Comparison of UnicoCell Biomed Co., Ltd.

Name Net Debt Net Debt Difference
Apex Biotechnology Corp. -201.21 Million TWD 127.051%
Sinphar Pharmaceutical Co.,Ltd. 870.53 Million TWD 93.747%
Panion & Bf Biotech Inc. 193.2 Million TWD 71.828%
Chunghwa Chemical Synthesis & Biotech Co., Ltd. 939.54 Million TWD 94.207%
GenMont Biotech Incorporation 2.71 Million TWD -1907.006%
Abnova (Taiwan) Corporation -415.8 Million TWD 113.09%
Adimmune Corporation 685.12 Million TWD 92.056%
Tanvex BioPharma, Inc. 1.35 Billion TWD 95.971%
Polaris Group -2.41 Billion TWD 102.25%
Energenesis Biomedical CO.,LTD. -246.6 Million TWD 122.071%
PELL Bio-Med Technology Co. Ltd. 4.88 Million TWD -1015.14%